Urachal and Nonurachal Adenocarcinomas of the Urinary Bladder: A Comprehensive Genomic Profiling Study.

Antonio Cigliola Alina BasnetJoseph M JacobChiara Mercinelli Valentina TateoDamiano Alfio PatanèGennady Bratslavsky Liang Cheng Petros D Grivas Ashish M Kamat Philippe E Spiess Dean C Pavlick Douglas I Lin Jeffery S Ross Andrea Necchi

Published in: JCO precision oncology (2024)

being identified as putative therapeutic targets. Biomarkers of response to anti-PD-(L)1 were uncommon. Results highlight the potential of CGP to personalize treatment options of bladder adenoCa and inform clinical trial designs.

Keyphrases

clinical trial
spinal cord injury
randomized controlled trial
study protocol
copy number
phase ii
open label
risk assessment
dna methylation